Full text is available at the source.
Abstract
Ketamine may provide a novel intervention for treatment-resistant depression and is being explored as an adjunctive treatment for addiction.
- Substance use disorders and treatment-resistant depression pose significant global health challenges.
- Existing treatments for these conditions often have high relapse rates and limited long-term effectiveness.
- Ketamine is associated with rapid neuroplastic effects, which could be beneficial for these disorders.
- Concerns about the potential for ketamine abuse remain a significant consideration in its use.
Simplified